EP3089729A4 - Compositions d'allantoïne pour traiter des affections cutanées inflammatoires - Google Patents

Compositions d'allantoïne pour traiter des affections cutanées inflammatoires Download PDF

Info

Publication number: EP3089729A4
Authority: EP; European Patent Office
Prior art keywords: skin conditions; inflammatory skin; treating inflammatory; allantoin; compositions
Prior art date: 2014-01-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP14876324.6A

Other languages

German (de)

English (en)

Other versions

EP3089729A1 (fr

Inventor

Elliott Farber

Robert Ryan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Scioderm Inc

Original Assignee

Scioderm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-01-03

Filing date

2014-01-03

Publication date

2017-06-14

2014-01-03 Application filed by Scioderm Inc filed Critical Scioderm Inc

2016-11-09 Publication of EP3089729A1 publication Critical patent/EP3089729A1/fr

2017-06-14 Publication of EP3089729A4 publication Critical patent/EP3089729A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Birds (AREA)
Dispersion Chemistry (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Gerontology & Geriatric Medicine (AREA)
Rheumatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP14876324.6A 2014-01-03 2014-01-03 Compositions d'allantoïne pour traiter des affections cutanées inflammatoires Withdrawn EP3089729A4 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2014/010248 WO2015102642A1 (fr)	2014-01-03	2014-01-03	Compositions d'allantoïne pour traiter des affections cutanées inflammatoires

Publications (2)

Publication Number	Publication Date
EP3089729A1 EP3089729A1 (fr)	2016-11-09
EP3089729A4 true EP3089729A4 (fr)	2017-06-14

Family

ID=53493841

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP14876324.6A Withdrawn EP3089729A4 (fr)	2014-01-03	2014-01-03	Compositions d'allantoïne pour traiter des affections cutanées inflammatoires

Country Status (7)

Country	Link
EP (1)	EP3089729A4 (fr)
JP (1)	JP2017502053A (fr)
AU (1)	AU2014374416A1 (fr)
BR (1)	BR112016015641A8 (fr)
CA (1)	CA2935836A1 (fr)
MX (1)	MX2016008795A (fr)
WO (1)	WO2015102642A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2015100348A1 (fr) *	2013-12-27	2015-07-02	Scioderm, Inc.	Réduction des chéloïdes au moyen d'allantoïne topique
GB201607814D0 (en)	2016-05-04	2016-06-15	5D Health Prot Group Ltd	Anti-microbial compositions
CN109091478A (zh) *	2017-06-20	2018-12-28	中国医学科学院药物研究所	尿囊素在制备抗高尿酸血症和抗痛风药物中的应用
CN111246888A (zh) *	2017-10-20	2020-06-05	日本乐敦制药株式会社	皮肤障碍改善用组合物
CN111773212A (zh) *	2020-08-14	2020-10-16	云南中医药大学	一种瑞香素的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5122533A (en) *	1990-06-20	1992-06-16	Bar On Ernest	Topical pharmaceutical compositions
EP1579861A2 (fr) *	2004-03-26	2005-09-28	Wilhelm R. Wolf	Onguent pour le soin des ongles et la thérapie ou le prévention de l'inflammation du tissu sous l'ongle et/ou l'inflammation de la muqueuse nasale
US20060134149A1 (en) *	1999-07-23	2006-06-22	Alwyn Company, Inc.	Methods for treatment of inflammatory diseases
WO2015100348A1 (fr) *	2013-12-27	2015-07-02	Scioderm, Inc.	Réduction des chéloïdes au moyen d'allantoïne topique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020054895A1 (en) *	1999-07-23	2002-05-09	Alwyn Company, Inc.	Allantoin-containing skin cream
US6281236B1 (en) *	1999-07-23	2001-08-28	Alwyn Company, Inc.	Oil-in-water emulsion with improved stability
US20080206155A1 (en) *	2006-11-14	2008-08-28	Foamix Ltd.	Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
WO2012053009A2 (fr) *	2010-10-21	2012-04-26	Cadila Healthcare Limited	Compositions pharmaceutiques comprenant des agents de décoloration de la peau
JP5769481B2 (ja) *	2011-04-15	2015-08-26	株式会社資生堂	ウフェナマート含有皮膚外用剤

2014
- 2014-01-03 CA CA2935836A patent/CA2935836A1/fr not_active Abandoned
- 2014-01-03 BR BR112016015641A patent/BR112016015641A8/pt not_active Application Discontinuation
- 2014-01-03 AU AU2014374416A patent/AU2014374416A1/en not_active Abandoned
- 2014-01-03 JP JP2016544415A patent/JP2017502053A/ja active Pending
- 2014-01-03 EP EP14876324.6A patent/EP3089729A4/fr not_active Withdrawn
- 2014-01-03 MX MX2016008795A patent/MX2016008795A/es unknown
- 2014-01-03 WO PCT/US2014/010248 patent/WO2015102642A1/fr active Application Filing

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5122533A (en) *	1990-06-20	1992-06-16	Bar On Ernest	Topical pharmaceutical compositions
US20060134149A1 (en) *	1999-07-23	2006-06-22	Alwyn Company, Inc.	Methods for treatment of inflammatory diseases
EP1579861A2 (fr) *	2004-03-26	2005-09-28	Wilhelm R. Wolf	Onguent pour le soin des ongles et la thérapie ou le prévention de l'inflammation du tissu sous l'ongle et/ou l'inflammation de la muqueuse nasale
WO2015100348A1 (fr) *	2013-12-27	2015-07-02	Scioderm, Inc.	Réduction des chéloïdes au moyen d'allantoïne topique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2015102642A1 *

Also Published As

Publication number	Publication date
WO2015102642A1 (fr)	2015-07-09
JP2017502053A (ja)	2017-01-19
AU2014374416A1 (en)	2016-07-21
CA2935836A1 (fr)	2015-07-09
BR112016015641A2 (pt)	2017-10-03
BR112016015641A8 (pt)	2017-10-10
MX2016008795A (es)	2017-03-23
EP3089729A1 (fr)	2016-11-09

Publication	Publication Date	Title
HK1243640A1 (zh)	2018-07-20	用於治療潰瘍的方法和組合物
EP3263132A4 (fr)	2018-08-01	Composition pour le traitement de maladies associées à il-6
EP3265053A4 (fr)	2018-08-08	Procédés de traitement de la peau
EP3142691A4 (fr)	2018-04-11	Méthodes et compositions de traitement de maladies auto-immunes et inflammatoires
EP3115386A4 (fr)	2017-11-29	Composition d'isocyanurate
EP3154595A4 (fr)	2018-01-24	Traitement de myélomes
PT3261726T (pt)	2019-06-25	Composição para o tratamento do acne
EP3135650A4 (fr)	2018-01-10	Adjuvant pour composition hydraulique
EP3189074A4 (fr)	2018-06-20	Compositions et méthodes pour traiter et prévenir l'inflammation
EP3139928A4 (fr)	2017-12-13	Compositions d'anordrine et méthodes de traitement de maladies
EP3126004A4 (fr)	2017-11-29	Méthodes et compositions pour le traitement de troubles inflammatoires
EP3110446A4 (fr)	2018-01-10	Procédés et compositions pour le traitement de maladies associées à siglec-8
EP3227276A4 (fr)	2018-08-01	Combinaisons pour le traitement du neuroblastome
EP3334432A4 (fr)	2019-03-13	Cerdulatinib pour le traitement du myélome
EP3164139A4 (fr)	2017-05-10	Compositions topiques et méthodes de traitement de plaies
EP3229813A4 (fr)	2018-07-25	Traitement d'une l'inflammation médiée par hmgb1
EP3122349A4 (fr)	2017-10-11	Compositions pour le traitement de l'autodigestion
EP3206670A4 (fr)	2018-06-20	Compositions pour le traitement de plaies
EP3164132A4 (fr)	2018-02-21	Méthodes et compositions pour le traitement de maladies et d'affections
EP3122743A4 (fr)	2017-11-29	Compositions et méthodes pour traiter des maladies neurodégénératives
EP3089729A4 (fr)	2017-06-14	Compositions d'allantoïne pour traiter des affections cutanées inflammatoires
EP3240533A4 (fr)	2018-07-11	Compositions et procédés pour traiter le glaucome
IL251394A0 (en)	2017-05-29	The compositions for reducing acidity
EP3104858A4 (fr)	2017-07-26	Méthodes de traitement de brûlures au moyen d'allantoïne
EP3145525A4 (fr)	2018-03-07	Utilisation de microperoxidases pour le traitement de la carboxyhémoglobinémie

Legal Events

Date	Code	Title	Description
2016-10-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2016-11-09	17P	Request for examination filed	Effective date: 20160803
2016-11-09	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2016-11-09	AX	Request for extension of the european patent	Extension state: BA ME
2016-12-07	RIN1	Information on inventor provided before grant (corrected)	Inventor name: FARBER, ELLIOTT Inventor name: RYAN, ROBERT
2017-04-12	DAX	Request for extension of the european patent (deleted)
2017-06-14	A4	Supplementary search report drawn up and despatched	Effective date: 20170517
2017-06-14	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/00 20060101ALI20170511BHEP Ipc: A61K 8/06 20060101AFI20170511BHEP Ipc: A61Q 19/00 20060101ALI20170511BHEP Ipc: A61K 47/06 20060101ALI20170511BHEP Ipc: A61K 8/49 20060101ALI20170511BHEP Ipc: A61Q 19/08 20060101ALI20170511BHEP Ipc: A61K 9/107 20060101ALI20170511BHEP
2017-08-16	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SCIODERM, INC.
2018-05-18	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1240073 Country of ref document: HK
2018-12-12	17Q	First examination report despatched	Effective date: 20181107
2019-09-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2019-10-23	18D	Application deemed to be withdrawn	Effective date: 20190518